These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12712514)

  • 1. [Biological importance of the anti-carnosine activity of bacteria].
    Bukharin OV; Stadnikov AA; Chernova OL; Kirgizova SB; Kovbyk LV; Boldyrev AA
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (4 Suppl):56-9. PubMed ID: 12712514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of temocillin against CTX-M-producing Escherichia coli and Klebsiella pneumoniae from Germany.
    Kresken M; Körber-Irrgang B; Pfeifer Y; Werner G
    Int J Antimicrob Agents; 2018 Jan; 51(1):159-160. PubMed ID: 28705669
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
    Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
    Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of fosfomycin against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: comparison of susceptibility testing procedures.
    de Cueto M; López L; Hernández JR; Morillo C; Pascual A
    Antimicrob Agents Chemother; 2006 Jan; 50(1):368-70. PubMed ID: 16377714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term study of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
    Polwichai P; Trakulsomboon S; Dejsirilert S; Thongmali O; Sawanpanyalert P; Aswapokee N; Buppanharun W
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S53-8. PubMed ID: 21294502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of stool colonization in patients infected with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
    Apisarnthanarak A; Bailey TC; Fraser VJ
    Clin Infect Dis; 2008 Apr; 46(8):1322-3. PubMed ID: 18444877
    [No Abstract]   [Full Text] [Related]  

  • 8. [Urinary tract infection by multiresistant Escherichia coli and Klebsiella pneumoniae: case report].
    Martín-Pozo Á; Oteo J; Sáez D; Alós JI
    Rev Esp Quimioter; 2012 Dec; 25(4):295-6. PubMed ID: 23303263
    [No Abstract]   [Full Text] [Related]  

  • 9. 3-acyloxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acids. An improved synthesis and biological properties.
    Berges DA
    J Med Chem; 1975 Dec; 18(12):1264-5. PubMed ID: 811800
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital.
    Kader AA; Kumar A
    Ann Saudi Med; 2005; 25(3):239-42. PubMed ID: 16119526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro bactericidal activity of cefepime and cefpirome against clinical isolates at Karachi.
    Arsalan A; Naqvi SB; Ali SA; Ahmed S; Shakeel O
    Pak J Pharm Sci; 2015 May; 28(3):841-7. PubMed ID: 26004702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nosocomial infection due to ESBL-producing bacteria].
    Yagi T
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():90-4. PubMed ID: 12717952
    [No Abstract]   [Full Text] [Related]  

  • 13. Frequency of Blood Culture Isolates and their Antibiogram in a Teaching hospital.
    Shrestha S; Amatya R; Shrestha RK; Shrestha R
    JNMA J Nepal Med Assoc; 2014; 52(193):692-6. PubMed ID: 26905550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amoxicillin: microbiological activity in vitro and in vivo (author's transl).
    Renzini G; Oliva B; Piccolomini R; Nicoletti M
    Antibiotica; 1973; 11(3-4):117-33. PubMed ID: 4619320
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibiotic resistance. Epidemiology of antibiotic resistance: blood and cerebrospinal fluid (CSF).
    Johnson AP; Speller DC
    J Med Microbiol; 1997 Jun; 46(6):445-7. PubMed ID: 9379470
    [No Abstract]   [Full Text] [Related]  

  • 16. [The biological significance of the anticomplement activity of bacteria].
    Brudastov IuA; Deriabin DG
    Zh Mikrobiol Epidemiol Immunobiol; 1994; Suppl 1():28-32. PubMed ID: 7856343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humanized tissue pharmacodynamics of cefazolin against commonly isolated pathogens in skin and skin structure infections.
    Jain JG; Housman ST; Nicolau DP
    J Antimicrob Chemother; 2014 Sep; 69(9):2443-7. PubMed ID: 24827890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of plasmid-mediated quinolone resistance genes in Escherichia coli and Klebsiella spp. recovered from Corvus brachyrhynchos and Corvus corax roosting in Canada.
    Janecko N; Halova D; Jamborova I; Papousek I; Masarikova M; Dolejska M; Literak I
    Lett Appl Microbiol; 2018 Aug; 67(2):130-135. PubMed ID: 29675942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic value of persistent characteristics of staphylococci during their carriage].
    Kartashova OL; Kirgizova SB; Potekhina LP; Bukharin OV
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (5):13-6. PubMed ID: 18038540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.